Patent · US Active

Crystalline solids of a MetAP-2 inhibitor and methods of making and using same

US9371312B2 · kind B2 · utility

1Cited by
32References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2014
Grant dateJun 21, 2016
Priority date—
Expiry dateFeb 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure is in part directed to crystalline forms of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol and variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.